Skip to content

Enovis ENOV Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

ESAB logo
ESABESAB
Vericel logo
VericelVCEL
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
Medtronic logo
MedtronicMDT
Baxter International logo
Baxter InternationalBAX
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-40.2%
Enterprise value$2.55B-25.8%
P/S0.5×-0.4×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's common stock, shares issued (in shares)?
Enovis (ENOV) reported common stock, shares issued (in shares) of $57.55M in Q1 2026.
How has Enovis's common stock, shares issued (in shares) changed year-over-year?
Enovis's common stock, shares issued (in shares) increased by 0.8% year-over-year, from $57.12M to $57.55M.
What is the long-term trend for Enovis's common stock, shares issued (in shares)?
Over 5 years (2020 to 2025), Enovis's common stock, shares issued (in shares) has grown at a -13.6% compound annual growth rate (CAGR), from $118.5M to $57.19M.